Category: News

May 17, 2023

Gilead Sciences on Tuesday named former Roche executive Cindy Perettie as the next head of its cell therapy business Kite Pharma, moving quickly to fill the vacancy left by Christi Shaw, who stepped down from the role at the end […]

May 11, 2023

NewBiologix SA launched as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The launch also includes the completion of a custom built 19,000 square-foot […]

May 10, 2023

Food and Drug Administration scientists evaluating what could be the first gene therapy for Duchenne muscular dystrophy appear skeptical of the treatment’s benefit, adding to questions about its approval prospects days before a crucial regulatory meeting. On Friday, the FDA […]

May 8, 2023

Through quantitative structure-activity relationship (QSAR) models, predictions can be made for a drug substance itself, intermediates, prioritizing experimental inquiries into the potential effects of newly identified drugs of abuse, and more. FDA’s Division of Applied Regulatory Science’s (DARS) computational toxicology […]

April 27, 2023

Lilly rival Novo Nordisk has a several year head start in selling insulin-modulating drugs for weight loss, first with a daily shot called Saxenda and, more recently, with a weekly shot named Wegovy. They both stimulate a hormone called GLP-1, […]

April 25, 2023

Biogen has stopped or paused several drug programs as part of a larger effort to cut costs and prioritize certain research. The decision, disclosed Tuesday in the company’s latest earnings report, comes as sales of its marketed medicines for brain […]

April 21, 2023

The Supreme Court on Friday allowed the abortion pill mifepristone to remain on the market for the time being, suspending a lower court order that would have curtailed its availability in the U.S. The 7-2 ruling stays a verdict earlier […]

April 13, 2023

The new drug looked so promising — except for that one warning sign. At the American College of Rheumatology’s annual meeting in 2008, Duke University’s Dr. John Sundy proudly announced that pegloticase, a drug he’d helped develop, was astoundingly effective […]

April 11, 2023

Curevo Vaccine, a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly effective vaccines, announced Guy De La Rosa has joined the company as its new chief medical officer. “The Curevo […]

April 4, 2023

Despite the headwinds young biotechs now face in raising capital, money is still flowing into venture firms. Data from the National Venture Capital Association shows that investment firms across industries raised about $163 billion last year and deployed nearly $31 […]

March 30, 2023

RoslinCT and Lykan Bioscience, companies involved in contract development and manufacturing for cell therapies, have been granted a Manufacturer’s Authorization License (MIA) for commercial manufacturing of cell therapy products from the Medicines and Healthcare products Regulatory Agency (MHRA), following a […]

March 30, 2023

In 2011, Jeffrey Motts was executed in South Carolina. More than a decade later, the state hasn’t carried out another execution because officials have struggled to obtain the drugs needed for lethal injection. Now, to resume executions, lawmakers are debating […]

March 29, 2023

The results are compelling when compared with approved drugs known as GLP-1 agonists that showed a reduction of between 0.5% and 0.8% in A1C after four weeks of treatment, Jefferies analysts wrote in a note to clients. Biomea also has […]

March 28, 2023

Shares of Intra-Cellular Therapies rocketed up Tuesday morning, after the New York-based biotechnology company unveiled positive clinical trial results for a depression medication that some analysts called a “clear win.” The medication, known scientifically as lumateperone and commercially as Caplyta, […]

March 21, 2023

Obesity treatments represent a huge market opportunity for drugmakers. Some analysts have projected annual sales as high as $50 billion for effective treatments, and developers have recently been sprinting to capitalize. The race has been focused on drugs in Wegovy […]

March 21, 2023

An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment. The drug’s maker, Novartis Pharmaceuticals Corp., has said it can’t keep up with demand for the medication, […]

March 20, 2023

During a four-hour hearing last week that could eliminate nationwide access to a common and widely used abortion pill, federal Judge Matthew Kacsmaryk, of the Northern District of Texas, signaled his conservative Christian beliefs early and often. Speaking from the […]

March 15, 2023

Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage blood test which identifies active tuberculosis (TB). The new function enables transportation […]

March 15, 2023

Jessica Layman estimates she has called more than 150 doctors in the past few years in her search for someone to prescribe opioids for her chronic pain. “A lot of them are straight-up insulting,” said the 40-year-old, who lives in […]

March 9, 2023

DRI Healthcare Trust, a prolific acquirer of drug royalties, is paying $100 million for a piece of a first-of-its-kind Type 1 diabetes drug. In an announcement Thursday, DRI said it bought royalties to the medicine, called Tzield and designed to […]